Arrayit Corporation (ARYC)

[BBstocks77]

Sunnyvale, March 11, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, increases weekly guidance for medical billing associated with its physician-prescribed allergy testing services from $1,000,000 ($1 million) per week as presented in the December 31 2018 CEO Letter to Shareholders, to $2,000,000 ($2 million) per week effective immediately. The 100% weekly guidance increase from $1 million to $2 million per week for fiscal year 2019 (FY2019) is based on medical billing growth during the first quarter of FY2019, the number of new clinics being added to our Patient Data Solutions portal, and the rate of allergy testing services adoption in the marketplace.
https://www.marketwatch.com/press-release/arrayit-corporation-increases-weekly-guidance-for-doctor-prescribed-allergy-testing-clinical-services-2019-03-11-61844929?siteid=bigcharts&dist=bigcharts